Revitalize Growth

August 12, 2026 | 16:00 – 17:00 GMT

Before your next compensation cycle, leaders should be asking one critical question: Is your sales compensation program working?

Join us virtually on Aug.12 for a tactical health check revealing what’s helping or hindering success. 

Alexander Group prepared an interactive session that will provide participants with a practical framework to assess the health of their current plans, benchmark against industry best practices and identify opportunities for improvement.

Session Objectives

• Benchmark your current sales compensation program against a proven health check framework
• Evaluate performance across the five tenets of a world-class sales compensation program.
• Assess plan design against market leading guidelines.
• Identify gaps, risks and opportunities for enhancement.
• Improve your ability to attract, motivate, reward and retain top sales talent.
• Develop actionable next steps to strengthen your program for 2027 and beyond.

Building on the insights shared during the programme health check session, attendees will have the opportunity to hear from peers, explore common challenges and develop actionable strategies to optimise their sales compensation programmes to better attract, motivate, reward and retain top sales talent.

Come prepared to assess your own programme, compare your approach against proven best practices and actively participate in peer discussions. Bring your questions, challenges and experiences to gain practical insights and leave with a clear action plan to strengthen your sales compensation strategy for 2027 and beyond.

Revolutionize your approach at the #1 event for sales compensation professionals and all executives who care about sales comp.
Designed specifically for executives in HR, Compensation, Sales and Revenue Operations that want to use sales comp more effectively.

Industry Focus: All

Building the Revenue-Ready Marketing Organization for Digital Health, MedTech, Pharma and Analytical Technology 

For today’s healthcare and life sciences marketing leaders, the mandate to prove revenue contribution has never been sharper. Yet every AI use case, data flow and campaign must clear a regulatory and compliance bar their peers in other industries never see.  

Alexander Group’s Revenue-Ready Marketing Organization research reveals that 74% of organizations have analytics/attribution AI actively deployed or scaled, yet 40% still operate with no formal (or only informal) AI governance and 48% cite data quality as a top three barrier. This combination is especially acute where patient data, HIPAA and promotional review constraints apply.  

How can healthcare and life sciences commercial leaders scale AI without tripping compliance and prove marketing’s revenue contribution to the board? 

Join Alexander Group’s Marketing practice leaders for this complimentary, virtual roundtable on how the most effective regulated-market organizations are simultaneously redesigning teams for AI under guardrails and proving pipeline economics with new attribution rigor.  

Drawing on the new research, this one-hour session will foster candid peer-level discussions on: 

• MLR-safe AI at scale: Deploying generative AI for medical/regulatory content, labeling and field enablement without breaking promotional review discipline.  
• The governance gap: The policy frameworks regulated markets need before scaling AI, and why “deploy first, govern later” fails hardest under promotional review. 
• Attribution in committee-driven buying: Proving contribution when a purchase runs through clinicians, procurement, compliance and finance—and 70% of evaluation happens before sales ever engage. 
• Enterprise unit economics: Managing $15K+ CAC and sub-12-month payback pressure in device, diagnostic and platform sales.  
• Customer-led growth: Why 33% of high-growth orgs are investing in customer journey architecture and content strategy to drive retention and expansion.  

Leaders will walk away with:  

• A governed-AI adoption model tuned for MLR, HIPAA and promotional-review realities, so you can scale without slowing.  
• Marketing-sourced pipeline and attribution benchmarks specific to healthcare and life sciences buying cycles.  
• Enterprise CAC, LTV: CAC and payback benchmarks to reframe your next board and CFO conversation.  
• A shared CMO–CRO language for aligning demand quality, seller coverage and forecast confidence.  
• Priority access to the Revenue-Ready self-diagnostic and the healthcare- and life sciences-specific briefings.  

Who Should Attend  

CMOs, CROs, CCOs and SVPs/VPs of Marketing and Sales at digital health, MedTech, medical device, biotech/pharma, pharma services, health insurance and analytical technology organizations.  

Attendance is limited and curated to protect candor. 

Join senior sales, marketing, commercial and operations leaders to share stories of transformation, connect 1:1 virtually and take away actionable ideas.